The presence of myocardial ischemia is the most important prognostic factor in patients with ischemic heart disease. Fractional flow reserve (FFR) is a gold standard invasive method used to detect the stenosis-specific myocardial ischemia. FFR-guided revascularization strategy is superior to angiography-guided strategy. The recently developed hyperemia-free index, instantaneous wave free ratio is being actively investigated. A non-invasive FFR derived from coronary CT angiography is now used in clinical practice. Due to rapid expansion of invasive and non-invasive physiologic assessment, comprehensive understanding of the role and potential pitfalls of each modality are required for its application. In this review, we focus on the basic and clinical aspects of physiologic assessment in ischemic heart disease.
INTRODUCTION
Myocardial ischemia can occur when myocardial perfusion cannot meet the demands of the myocardium and is a key prognostic factor in patients with coronary artery disease (1, 2) . Numerous efforts are made to detect the presence of myocardial ischemia. Despite many available non-invasive tests, it is reported that about 60% of patients referred Physiologic Assessment of Coronary Artery Disease: Focus on Fractional Flow Reserve Doyeon Hwang, MD 1 kjronline.org achieve maximal hyperemia for FFR measurement (11) . Intravenous infusion of adenosine can cause chest discomfort, atrioventricular conduction delay and bronchial hyper-reactivity, although their incidences and clinical significance are low. Intracoronary bolus administration of adenosine is a simple method for hyperemia induction, and injection of 50-200 μg of adenosine is considered adequate for FFR measurement (12) . However, due to its short action time, steady state hyperemia for pressure pullback tracing cannot be maintained with a single bolus administration of adenosine. Besides adenosine, nicorandil and regadenoson are recently introduced as novel hyperemic agents. Nicorandil (Sigmart ® , Chugai Pharmaceutical, Tokyo, Japan) is a nicotinamide ester with dual mechanisms of action on both macro-and microvascular systems (13, 14) . Jang et al. (13) report similar hyperemic efficacy between intracoronary nicorandil injection (2 mg) and intravenous infusion of adenosine. Compared with adenosine, nicorandil causes less frequent adverse effects (pressure change, heart rate change, chest discomfort). The excellent diagnostic efficacy and safety of intracoronary bolus administration of nicorandil are confirmed at the patient-level pooled data from 429 patients with 480 coronary arteries (r = 0.941, intra-class correlation coefficient 0.980, classification agreement 90.8%, kappa = 0.814, area under curve of nicorandil 0.980, all p < 0.001) (15) . Regadenoson is a direct A2A adenosine receptor agonist that can be administered as a single bolus intravenous injection. It has rapid onset but longer duration of action and fewer adverse effects, as compared with adenosine (16, 17) . Lim et al. (18) compared intravenous infusion of adenosine, intracoronary bolus injection of adenosine, intracoronary bolus injection of nicorandil and regadenoson and reported that FFR values were not significantly different among the different hyperemic agents. The study results on the currently available hyperemic agents are summarized in Table 1 .
Clinical Evidence of FFR-Guided Revascularization Landmark Studies of FFR-Guided Strategy
The optimal cut-off value of FFR for defining inducible myocardial ischemia is extensively investigated using non-invasive stress tests. Pioneer work of Pijls et al. (6) proposed a cut-off value of 0.75, based on the comparison of invasive FFR and the results of sequential tests of exercise-stressed tests, thallium scintigraphy, 6). Flow is proportional to pressure in the case of minimal and constant resistance, thus pressure can be a surrogate of flow during maximal hyperemia (Fig. 1) . As distal coronary artery pressure (Pd) in a normal coronary artery is almost the same as the aortic pressure (Pa), normal perfusion pressure can be replaced by Pa. As venous pressures are generally negligible compared to arterial pressure, FFR can be simply calculated as the ratio of Pd to Pa during maximal hyperemia (4) (5) (6) . The definition and an example of FFR measurement are shown in Figure 2 . FFR of 0.80 indicates that the diseased coronary artery supplies 80% of the normal maximal flow due to the stenosis. The strength of FFR is that it can assess the degree and presence of epicardial lesion-specific inducible myocardial ischemia, not only in cases with negative or ambiguous results of non-invasive functional tests, but also in the presence of multivessel disease (Figs. 3, 4) . FFR also has excellent reproducibility, regardless of changes in hemodynamics or myocardial contractility (7) (8) (9) .
As previously mentioned, a linear relationship between coronary flow and pressure is the fundamental assumption in the concept of FFR. As coronary blood flow and resistance are auto-regulated based on the myocardial demand, within the physiological range (10), induction of maximal hyperemia or minimizing microvascular resistance is mandatory for FFR measurement (5, 6) . Continuous intravenous infusion of adenosine (140 μg/ kg/min) is considered as a gold standard method to kjronline.org and dobutamine-stress echocardiography (sensitivity 88%, specificity 100%, positive predictive value 100%, negative predictive value 88%, and accuracy 93%). Using the ischemic cut-off value of FFR, the first randomized study of FFR-guided percutaneous coronary intervention (PCI), the DEFER trial, tested the safety of deferral of functionally insignificant stenosis (19 Multivessel Evaluation 2 (FAME 2) trial compared FFR-guided PCI plus optimal medical therapy with optimal medical therapy alone in patients with functionally significant stenosis (FFR ≤ 0.80) (25, 26) . In this study, patients with a functionally significant lesion (FFR ≤ 0.80) were randomly assigned to FFR-guided PCI plus optimal medical therapy group and only optimal medical therapy group, whereas patients with FFR > 0.80 in all stenoses received optimal medical therapy and were assigned as a registry group. The study was halted prematurely because of the significant difference of composite of death, MI or urgent revascularization (4.3% for FFR-guided PCI group vs. 12.7% for optimal medical therapy group, p < 0.001) (25, 26) . Accordingly, European guidelines recommend FFR-guided kjronline.org revascularization with Class I (level of evidence A) in stable patients when evidence of ischemia is not available (27) . kjronline.org guided strategy over angiography-guided strategy is also demonstrated (32, 33) . These investigations collectively support the safety and effectiveness of an FFR-guided strategy, which reduces unnecessary stent implantation and enhances patient's clinical outcome.
Further Evidences for FFR-Guided Revascularization
In addition to the robust data supporting the FFR-guided decision making process, recent investigations increase our understanding of coronary physiology and FFR. In metaanalysis at the study-level (n = 9173) as well as individual patient-level (n = 6961), Johnson et al. (34) 
Resting Physiologic Index without Hyperemia
The concept of instantaneous wave free ratio (iFR) was originally derived from wave-intensity analysis using both intracoronary pressure and flow velocity data. Davies et al. (35) report a certain period in the cardiac cycle when the resistance is low and stable (36) . iFR is calculated by Pd/Pa ratio at the wave-free period during resting state and does not require hyperemia (Fig. 5) . The ADenosine Vasodilator Independent Stenosis Evaluation (ADVISE) is the first study to evaluate the concept of iFR (37) . In this study, iFR was closely correlated with FFR (r = 0.9, p < 0.001) and showed excellent diagnostic performance (C-statistics 0.93) to predict low FFR. In the ADVISE study, the optimal cut-off kjronline.org value of iFR to predict FFR < 0.80 was 0.83 with sensitivity, specificity, positive predictive value, and negative predictive value of 85%, 91%, 91%, and 85%, respectively (37) . Subsequent to the introduction of iFR, its diagnostic accuracy and validity during resting period have been under debate (38) (39) (40) . In this regard, the large scale RESOLVE study was designed to investigated the data of 1768 patients from 15 international centers. In this study, iFR was measured using a uniform calculation algorithm in the independent physiologic core laboratory (41) . As a result, the optimal cut-off value of iFR was 0.90 for FFR ≤ 0. 
Non-Invasive Assessment for FFR: CT-Derived FFR
Coronary CT angiography (cCTA) provides accurate anatomical information. However, the discrepancy between anatomical severity and functional significance is wellknown (8, (43) (44) (45) (46) (47) (48) (49) (50) . With the advancement of computational kjronline.org fluid dynamics (CFD) technology, CT-derived FFR (FFRCT) has been developed to provide a non-invasive estimate of FFR (Fig. 6 ). The FFRCT technology possesses a robust scientific basis that is well described in previous reviews (51) (52) (53) . Briefly, a three-dimensional patient specific anatomic model of coronary artery is first constructed from the cCTA data. For assigning boundary conditions of CFD simulation, the basal coronary outlet resistances at resting state are determined from the principle of an allometric scaling law, which allows the estimation of total coronary flow from myocardial mass; and a morphometry law, which relates the resistance of the downstream vessel to the vessel size at each outlet. A mathematical model of hyperemic condition is derived from the effect of adenosine on reducing the resistance of the coronary microcirculation. Lastly, on the basis of discretized model of patient-specific geometry and boundary conditions, CFD analysis is performed to numerically solve the governing equations of fluid dynamics, i.e., Navier Stokes equations, as a Newtonian fluid. The numerical solutions of coronary flow and pressure fields are used to compute a complete spatial distribution of FFRCT. (54) (55) (56) . The obvious benefit in cost-effectiveness of a FFRCT-guided clinical decision making process is also presented using the previous trial populations, as compared with traditional clinical decision making process (57, 58) .
Furthermore, the recently published Prospective LongitudinAl Trial of FFRCT: Outcome an Resource Impacts (PLATFORM) trial evaluates clinical outcomes of FFRCT-guided diagnostic strategy, compared with usual care of patients with suspected coronary artery disease in real-world practice (59) . Among those with intended invasive coronary angiography (FFRCT-guided = 193; usual care = 187), no obstructive coronary artery disease was found at the time of invasive angiography in 24 (12%) in the cCTA/FFRCT arm and 137 (73%) in the usual care arm (risk difference 61%, 95% CI 53-69, p < 0.0001), with similar mean cumulative radiation exposure (9.9 mSv vs. 9.4 mSv, p = 0.20). In Study about impact of FFRCT on clinical practice FFRCT guided group showed significantly lower portion of no obstructive CAD than usual group in ICA (12% vs. 73%) Also, cCTA/FFRCT guided strategy decreased ICA about 61% Early adverse events for 90 days were similar between cCTA/FFRCT guided group and usual group CAD = coronary artery disease, cCTA = coronary computed tomography angiography, FFRCT = computed tomography derived fractional flow reserve, ICA = invasive coronary angiography, NPV = negative predictive value, PPV = positive predictive value kjronline.org addition, invasive coronary angiography was ruled out in 61% after FFRCT (59) . These results suggest the potential of FFRCT as a non-invasive diagnostic modality in the clinical decision-making process. The investigators in DISCOVER-FLOW evaluate the potential of FFRCT technology in planning the treatment strategy using the so-called "Virtual PCI technology" (60) . Modification of the computational model to restore the area of the target lesion according to the proximal and distal reference areas (i.e., virtual stenting), allows for estimation of post-interventional FFRCT values (60) . Kim et al. (60) evaluated this novel strategy in 44 patients who had functionally significant coronary stenoses with available pre-intervention coronary cCTA and pre-and postintervention FFR values. Both pre-and post-interventional values of invasive FFR and FFRCT showed an excellent correlation. The mean difference between FFRCT and FFR was 0.006 for pre-intervention (95% limit of agreement: -0.27 to 0.28) and 0.024 for post-intervention (95% limit of agreement: -0.08 to 0.13). Diagnostic accuracy of FFRCT to predict ischemia (FFR ≤ 0.8) prior to stenting was 77% (sensitivity: 85.3%, specificity: 57.1%, PPV: 83%, and NPV: 62%) and after stenting was 96% (sensitivity: 100%, specificity: 96%, PPV: 50%, and NPV: 100%). The value of FFRCT as a "treatment planner" is still under development and needs further investigation.
In addition to FFRCT, several investigators are working with new methodologies for non-invasive estimation of FFR using cCTA or angiograms (61) (62) (63) . Furthermore, the clinical relevance of comprehensive hemodynamic assessment using cCTA and CFD is under active investigation (64) . However, any non-invasive FFR from cCTA requires adequate anatomic geometries and physiologic boundary conditions for CFD analysis. Adherence to established best image acquisition kjronline.org practices, including heart rate control and use of pre-scan nitroglycerin, is essential to improve cCTA image quality. Further refinement of this technology is expected to improve its diagnostic accuracy and contribute to better patient care in clinical practice.
Microvascular Assessment and Comprehensive Physiologic Evaluation
Although FFR is now regarded as the gold-standard invasive method to assess the functional significance of coronary artery stenosis (65) , there is still room for further improvement in the diagnosis and treatment of patients with high FFR. In the FAME 2 study, 14.6% of the registry arm (FFR > 0.80 and deferral of PCI) experienced persistent angina, and 9.0% of these patients had clinical events during a 2-year follow-up period (66) . This observation suggests that the ischemic heart disease cannot be fully explained by epicardial stenosis alone. The coronary artery system has 3 components with different functions (conductive epicardial coronary arteries, arterioles, and capillaries), hence, failure of any one of these systems could result in myocardial ischemia. Thus, the presence of epicardial coronary artery stenosis is not the sole factor for ischemic heart disease (67) .
In this regard, previous studies have suggested that the measurement of coronary flow reserve (CFR) could be helpful in risk stratification for patients with high FFR (> 0.80). Previous studies report that low CFR has worse clinical outcome than normal CFR in the setting of normal FFR patients, implying that dysfunction or disease in microvascular circulatory beds are also contributors to ischemic heart disease, especially in the case of functionally insignificant epicardial stenosis (68) (69) (70) . An index of microcirculatory resistance (IMR) is currently introduced, since CFR is largely influenced by variations in the resting coronary flow and not a microcirculatory bed-specific index. IMR is a pressure-temperature derived kjronline.org parameter for quantifying microcirculatory resistance (71) . As distal coronary pressure is used in the calculation of IMR, this index can be used to interrogate selectively the microcirculation of vessels with a coronary stenosis, in contrast to CFR, which is a combined assessment of the macro-and microcirculation. Table 3 summarizes previous evidence regarding IMR (72) (73) (74) (75) (76) (77) (78) (79) (80) (81) . According to the evidence of CFR and IMR, high FFR, low CFR and high IMR suggest the presence of microvascular disease in the coronary circulatory bed. Figure 7 shows an example of a patient with microcirculatory disease.
Therefore, comprehensive evaluation using multiple physiologic indices should be regarded as a diagnostic approach to enhance the stratification of patients, according to major compartment(s) involved in the development of ischemic heart disease.
Conclusions and Future Perspectives
This review focuses on the invasive physiologic assessment of ischemic heart disease, and presents evidence for its clinical relevance and effectiveness in the enhancement of patient's clinical outcomes. Despite the low prevalence of invasive physiologic assessment in daily practice, recently developed novel indices and hyperemic agents are expected to reduce the current barriers. Furthermore, comprehensive assessment of both macro-and microvascular systems and practical application of cCTA-derived non-invasive FFR will further improve clinical outcomes of patients with ischemic heart disease.
